✦ LIBER ✦
510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation
✍ Scribed by Asifa Malik; Carlos Bueso-Ramos; Stefan Faderl; Eli Estey; Susan O'Brien; Michael Fernandez; Martin Nguyen; Charles Koller; Emil Freireich; Miloslav Beran; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Farhad Ravandi
- Book ID
- 119218763
- Publisher
- Elsevier
- Year
- 2011
- Tongue
- English
- Weight
- 153 KB
- Volume
- 11
- Category
- Article
- ISSN
- 2152-2650
No coin nor oath required. For personal study only.